Castellan Group Takes Position in McKesson Corporation $MCK

The firm bought 8,130 shares of the company's stock, valued at approximately $6,669,000.

Apr. 13, 2026 at 8:09am

Got story updates? Submit your updates here. ›

An extreme close-up of gleaming, industrial banking machinery and equipment, conceptually representing the secure, powerful systems that underpin the financial sector.Castellan Group's investment in McKesson Corporation reflects confidence in the healthcare distribution industry's robust financial infrastructure.Irving Today

Castellan Group bought a new stake in McKesson Corporation (NYSE:MCK) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 8,130 shares of the company's stock, valued at approximately $6,669,000. McKesson accounts for 0.8% of Castellan Group's investment portfolio, making the stock its 10th biggest holding.

Why it matters

This investment by Castellan Group in McKesson Corporation, a major healthcare services and distribution company, signals confidence in the firm's long-term prospects and potential for growth within the pharmaceutical and medical supply industries.

The details

Castellan Group, an investment management firm, has taken a new position in McKesson Corporation, one of the largest pharmaceutical distributors in the United States. The firm purchased 8,130 shares of McKesson stock, valued at approximately $6.67 million, making it the 10th largest holding in Castellan's investment portfolio.

  • Castellan Group bought the new stake in McKesson during the 4th quarter of 2025.

The players

Castellan Group

An investment management firm that has taken a new position in McKesson Corporation.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions.

Got photos? Submit your photos here. ›

The takeaway

This investment by Castellan Group in a major healthcare distribution company like McKesson suggests the firm sees long-term growth potential in the pharmaceutical and medical supply industries, which could signal broader confidence in the sector's future performance.